Numinus Bioscience

A Center for Excellence

Numinus Bioscience is a global leader in supporting and expanding the safe, accessible, and evidence-based use of psychedelic-assisted psychotherapies. Operating a state-of-the-art research facility in British Columbia, Canada, Numinus Bioscience holds a Controlled Drugs and Substances license issued by Health Canada to allow the possession, production, assembly, sale, export, and delivery for a wide variety of psychedelic compounds and natural source materials, including Psilocybe mushroom fruiting bodies and extracts, Psilocybin, Psilocin, Ketamine, LSD, DMT and Mescaline.

Numinus has established itself at the forefront of psychedelic therapeutic development and as a supporting arm for psychedelic therapy clinical trials.

Woman testing psychedelic compounds for purity

Industry Leaders

A leader in therapeutic development, psychedelics R&D, Numinus Bioscience has invested in next-generation equipment to increase efficiency and accuracy as well as ensure compliance with good practices in ground-breaking areas of research. We adhere to ISO, Good Laboratory Practices, Good Manufacturing Practices, and Good Agricultural and Collection Practices. Our objective is to ensure our clients receive the best service in the industry.

The Bioscience Team

Bioscience Updates